| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |